Global Women's Soccer Trial Achieves 65% Reduction in ACL Injuries Through New Biomechanical Protocols

For the better part of a decade, women's soccer has been haunted by a quiet epidemic. Anterior cruciate ligament (ACL) tears have routinely sidelined the sport's brightest stars, robbing tournaments of generational talents and cutting promising careers short. But a landmark announcement in Geneva this weekend signals that the tide has finally turned.[1][3]

FIFPRO, the global players' union, alongside the European Club Association (ECA), unveiled the final results of a three-year biomechanical trial known as 'Project ACL.' The findings, simultaneously published in the British Journal of Sports Medicine, are staggering: participating clubs saw a 65% reduction in non-contact ACL injuries over two seasons.[5][6]

The breakthrough stems from a fundamental shift in how the sport treats the female body. Historically, sports science in soccer operated on a 'shrink it and pink it' philosophy, where boots and training regimens designed for men were simply scaled down for women. This trial discarded that approach entirely, building a protocol from the ground up based on female anatomy.[2][3]

The first major intervention focused on footwear. Research demonstrated that traditional bladed studs, designed to support the heavier mass and different center of gravity of male players, created too much rotational traction for women. When a female player planted her foot to pivot, the boot stayed locked in the turf, transferring the rotational force directly to the knee joint.[1][6]

To combat this, the 24 participating clubs—spanning the English Women's Super League, Spain's Liga F, Germany's Frauen-Bundesliga, and the NWSL—mandated the use of newly engineered boots. These models feature shorter, conical studs that allow the foot to release from the grass more easily during high-speed directional changes, drastically reducing the torque on the ACL.[4][7]

The second, and perhaps more revolutionary, intervention involved physiological tracking. The trial implemented training loads that were dynamically synced to each player's menstrual cycle. Sports scientists have long known that hormonal fluctuations, particularly spikes in relaxin and estrogen during the ovulatory and luteal phases, can increase ligament laxity—essentially making the joints looser and more prone to hyper-extension.[5][6]

Under the new protocol, clubs adjusted their weekly regimens. During high-risk hormonal windows, players were rotated out of heavy deceleration drills and plyometrics, focusing instead on straight-line speed, tactical walkthroughs, or upper-body conditioning. The adjustments were subtle enough not to disrupt match preparation, but targeted enough to protect vulnerable joints.[2][8]

The results exceeded all expectations. Not only did catastrophic knee injuries plummet by 65%, but the clubs also reported a 40% drop in overall lower-limb soft tissue injuries, including hamstring and calf strains. The holistic approach to female biomechanics yielded a healthier, more resilient player pool across the board.[1][6]

For the players, the data brings a profound sense of relief mixed with lingering frustration. Union representatives noted that female athletes had been complaining about ill-fitting boots and grueling, unsynced schedules for years. The success of Project ACL is viewed as a vindication of their long-standing demands for bespoke medical care.[3][5]

The ripple effects are already reshaping the sporting goods industry. Major manufacturers, who partnered with FIFPRO for the trial, have committed to retooling their assembly lines. By the end of 2026, female-specific stud configurations and wider toe boxes will become the default standard for women's boots, rather than a niche specialty item.[2][7]

Club management boards are also celebrating the financial implications. As transfer fees and wages in the women's game continue to break records, protecting those investments has become a paramount concern. Having star players available for a full 30-game season rather than spending nine months in the rehabilitation room dramatically improves a club's return on investment.[4][8]

The next challenge is democratization. While elite clubs have the resources to monitor hormonal cycles and provide custom footwear, the vast majority of ACL injuries occur at the grassroots and youth academy levels, where bad biomechanical habits often take root. FIFPRO is now lobbying UEFA and FIFA to subsidize these boots for youth leagues.[1][5]

Medical experts emphasize that while the 65% reduction is a monumental victory, the risk of ACL tears can never be reduced to zero in a high-impact contact sport. Collisions, awkward landings, and sheer bad luck will always play a role. However, eliminating the preventable, non-contact injuries changes the landscape of the sport entirely.[3][6]

The success of the soccer trial is also catching the attention of other sports. Basketball and rugby federations have reached out to the research team, eager to see if similar footwear and cycle-syncing protocols could curb the injury rates in their own female leagues.[2][5]

Ultimately, the legacy of this trial extends far beyond the pitch. It represents a definitive end to the era of treating female athletes as an afterthought in sports science. By finally listening to the specific needs of the female body, the sport has unlocked a safer, more sustainable future for its players.[3][8]